semaj83/ctmatch_classification huggingface dataset:
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Adenocarcinoma Cervical Adenocarcinoma In Situ Cervical Intraepithelial Neoplasia Cervical Squamous Cell Carcinoma, Not Otherwise Specified Cervical Squamous Intraepithelial Neoplasia Early Invasive Cervical Adenocarcinoma Early Invasive Cervical Squamous Cell Carcinoma High Grade Cervical Squamous Intraepithelial Neoplasia High Grade Vaginal Intraepithelial Neoplasia Low Grade Vaginal Intraepithelial Neoplasia Stage I Cervical Cancer AJCC v8 Stage I Vaginal Cancer AJCC v8 Stage I Vulvar Cancer AJCC v8 Stage IA Cervical Cancer AJCC v8 Stage IA Vaginal Cancer AJCC v8 Stage IA Vulvar Cancer AJCC v8 Stage IA1 Cervical Cancer AJCC v8 Stage IA2 Cervical Cancer AJCC v8 Stage IB Cervical Cancer AJCC v8 Stage IB Vaginal Cancer AJCC v8 Stage IB Vulvar Cancer AJCC v8 Stage IB1 Cervical Cancer AJCC v8 Stage IB2 Cervical Cancer AJCC v8 Stage II Cervical Cancer AJCC v8 Stage II Vaginal Cancer AJCC v8 Stage II Vulvar Cancer AJCC v8 Stage IIA Cervical Cancer AJCC v8 Stage IIA Vaginal Cancer AJCC v8 Stage IIA1 Cervical Cancer AJCC v8 Stage IIA2 Cervical Cancer AJCC v8 Stage IIB Cervical Cancer AJCC v8 Stage IIB Vaginal Cancer AJCC v8 Stage III Cervical Cancer AJCC v8 Stage III Vaginal Cancer AJCC v8 Stage III Vulvar Cancer AJCC v8 Stage IIIA Cervical Cancer AJCC v8 Stage IIIA Vulvar Cancer AJCC v8 Stage IIIB Cervical Cancer AJCC v8 Stage IIIB Vulvar Cancer AJCC v8 Stage IIIC Vulvar Cancer AJCC v8 Stage IV Cervical Cancer AJCC v8 Stage IV Vaginal Cancer AJCC v8 Stage IV Vulvar Cancer AJCC v8 Stage IVA Cervical Cancer AJCC v8 Stage IVA Vaginal Cancer AJCC v8 Stage IVA Vulvar Cancer AJCC v8 Stage IVB Cervical Cancer AJCC v8 Stage IVB Vaginal Cancer AJCC v8 Stage IVB Vulvar Cancer AJCC v8 Vaginal Adenocarcinoma Vulvar Adenocarcinoma Vulvar High Grade Squamous Intraepithelial Lesion Vulvar Intraepithelial Neoplasia Vulvar Squamous Cell Carcinoma Vulvar Squamous Intraepithelial Lesion Women with histologically confirmed cervical, vaginal or vulvar high-grade dysplasia, invasive squamous cell carcinoma, invasive adenocarcinoma, or adenocarcinoma-in-situ (AIS). All stages and grades will be eligible Women with a diagnosis of high grade intraepithelial lesion (HSIL) from a routine pap test Patients must sign an approved informed consent document  Patients with previously documented perianal squamous cell dysplasia or invasive squamous cell carcinoma of the anus or anal canal Patients unwilling or unable to provide informed consent for the study Male patients will not be included in this study Patients with previously documented HPV related oropharyngeal cancer
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Nicotine Dependence Cigarette Smoking Alcohol Consumption Heavy Drinking are at least 18 years of age; 2. report smoking 100 cigarettes over lifetime and currently smoke at least twice weekly on average in the past 90 days and have a urinary cotinine level of >=30ng/mL by semi-quantitative analysis, and/or >= 2 on a NicAlert dipstick 3. are interested in quitting smoking; 4. understand English; 5. exceed National Institute on Alcohol Abuse and Alcoholism heavy drinking (i.e., for men, >14 drinks/week or 5 drinks/day at least once per month over the past 12 months; for women, >7 drinks/week or >4 drinks/day at least once per month over the past 12 months  meet for alcohol dependence in the past 12 months that is clinically severe defined by a history of seizures, delirium, or hallucinations during alcohol withdrawal a Clinical Institute Withdrawal Assessment scale (Sullivan et al., 1989) score of > 8 report drinking to avoid withdrawal symptoms, or d) have had prior treatment of withdrawal have required medical treatment of alcohol withdrawal within the past 6 months; 2. are currently enrolled in alcohol treatment; 3. meet for drug dependence in the past 12 months; with the exception of marijuana dependence 4. exhibit serious psychiatric illness (i.e., schizophrenia, bipolar disorder, severe major depression, panic disorder, borderline personality disorder, organic mood or mental disorders by history or psychological examination; 5. report current suicidality (past 12 months), or report suicide attempts within the past 10 years, assessed with the Columbia Suicide Severity Rating Scale; 6. exhibit current, clinically significant physical disease or abnormality based on medical history, physical examination, or routine laboratory evaluation including any unexplained elevations in liver enzymes (i.e., transaminases, bilirubin) clinically significant, unstable cardiovascular disease/uncontrolled hypertension hepatic or renal impairment severe obstructive pulmonary disease diabetes mellitus requiring insulin or certain oral medications (i.e., sulfonylureas) and an A1C hemoglobin test score of > 7 for participants not prescribed these medications
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-55.0,  Healthy Have a weight in the range of 50.0 kilogram (kg) to 90.0 kg, inclusive and a body mass index (BMI) of 18.5 kilogram per square meter (kg/m^2) to 29.0 kg/m^2, inclusive If a woman, she must be incapable of pregnancy or using a highly effective method of birth control A woman must have a negative serum pregnancy test A man who is sexually active with a woman of childbearing potential and has not had a vasectomy must agree to use a barrier method of birth control Participant must be willing and able to adhere to the prohibitions and restrictions specified in this protocol Are nonsmokers or agree to smoke no more than 10 cigarettes or 2 cigars per day throughout the study  Participant currently has or has a history of any clinically significant medical illness or medical disorders including malignancy Participant has previously received ustekinumab Participant has a known or suspected intolerance or hypersensitivity to any biologic medication including ustekinumab Participant has received an investigational drug within a specified period prior to the planned first dose of study drug or is currently enrolled in an investigational study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Poor Platelet Transfusion Outcome adult hematology-oncology outpatients stable and thrombocytopenic  age <18 yrs splenomegaly unable to provide informed consent pregnancy acute promyelocytic leukemia ITP (Idiopathic thrombocytopenic purpura) HUS
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Healthy Healthy, sexually active woman at risk for pregnancy seeking to use hormonal contraception for at least 1 year Ability to demonstrate willingness to participate and adhere to study protocol  Known or suspected pregnancy Lactating women Anticipates use of condoms or any other form of back-up contraception during the study History of dermal sensitivity to medicated patches (nicotine) or to bandages, surgical tape, etc Has a contraindication to combined estrogen-progestin contraceptive use Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic) Smoker who is 35 years old or over
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-29.0,  Facial Expressions Healthy subjects, no smoke or drink alcohol, coffee or other stimulants during the day before Experiment  history of head injury; pregnancy; uterine cavity operations were took within one year; medical or psychiatric illness; rhinitis in case they may not fully absorb the spray
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 15.0-80.0,  Cervical Intraepithelial Neoplasia Cervix Neoplasms indication of cold knife conization  conization using techniques other than the cold knife previous cervical conization using any other technique previous pelvic radiotherapy pregnancy; and refusal to participate in the study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-55.0,  Bacterial Vaginosis For BV Subjects: (140 subjects) Premenopausal women over the age of 18 who have BV who are willing to sign informed consent Positive for all Amsel Vaginal pH > 4.5 Positive amine test > 20% clue cells on wet mount Grayish-white adherent discharge Subject is willing to refrain from using any vaginal medications, douches or spermicides except for the metronidazole suppositories that are given to her for the duration of the study Subject is willing to use supplied non-lubricated condoms when sexually active. But not to have sexual intercourse within 48 hours of any Study Visit Subject to refrain from alcohol for 24 hours prior to the first 7 days of the metronidazole treatment and for 48 hours after completion of this treatment. for Healthy control group  Study for BV Study Subjects Mixed vaginal infection at time of enrollment Pregnancy, nursing or planning on getting pregnant Subject on anticoagulation therapy, lithium therapy or Antabuse therapy Vaginal bleeding at time of enrollment Allergy to metronidazole Use of any vaginal antibiotics or antifungals in the previous 10 days, from enrollment Must not require treatment for an abnormal Pap smear or genital cancer Must abstain from vaginal douching during enrolled period. Study for Control Subjects
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Cervical Dysplasia HIV -infected women whose biopsy proves CIN1 and who consent to study participants and procedures CIN1 with no visible lesion The entire ectocervical lesion should cover less than 75% of the cervix and not more than 2 m into the endocervical canal  Pregnant women Known and previous treatment for HSIL by any method (Cryotherapy, LEEP or cone biopsy) Women who are menstruating or who have active pelvic inflammatory disease will be deferred from the study until the infection is cleared or the menstrual cycle has ended; the patient may then participate in the study Unsatisfactory colposcopic examination defined as inability to see the extent of the lesion in the endocervical canal and lesions deemed ineligible for cryotherapy by an OB/GYN specialist Previous hysterectomy with removal of the cervix
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Severe Alcoholic Hepatitis in 'Extremis'- Defined by mDF>54 Severe Alcoholic hepatitis (mDF > 54) 2. Age 18-65 Year 4. Actively consuming alcohol within 6 weeks of entry into the study  Failure to obtain informed consent 2. Active infection or sepsis 3. Other concomitant causes of liver disease: viral hepatitis, autoimmune liver disease, metabolic liver disease, vascular liver disease 4. HIV positive 5. Cow milk allergy or severe lactose intolerance 6. Active Gastrointestinal bleeding 7. Acute kidney injury at time of randomization with Creatinine > 1.5 mg/dL 8. Evidence of acute pancreatitis or biliary obstruction 9. Subjects who are pregnant or lactating 10. Significant systemic cardio-pulmonary illness 11. Patients requiring the use of vasopressors or inotropic support in 12 hours prior to randomization 12. Treatment for alcoholic hepatitis within 1 month of study entry with corticosteroids use>1 week. 13. Any patient who has received any investigational drug or device within 30 days entering into the study
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Cervical Cancer abnormal cervical cancer screening by pap smear of high risk HPV test -  no consent -
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Lichen Planus, Oral Patient ≥ 18 years Clinical and/or histological diagnosis of erosive or atrophic OLP No signs of severe dysplasia at the sampling  o immunosuppressive or anti-inflammatory therapies at the
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Alcohol Dependence Experienced binge drinking episode(s) (5 or more standard drinks for men and 4 or more standard drinks for women consumed in about 2 hours according to NIAAA definition) in the past 30 days  DSM-IV diagnosed alcohol dependence, other drug dependencies including nicotine dependence
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer Participant is willing and able to give informed consent for participation in the study Participant is literate in German, French, Italian or English Female, aged 18 years or above Histologically confirmed CIN3+ lesions, i.e. CIN3, adenocarcinoma in situ and invasive carcinoma of the cervix Participant resides in the canton Zurich, Geneva, Basel, Baselland, Luzern or Ticino  None
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-80.0,  Uterine Cervical Dysplasia histologically proven cervical dysplasia colposcopy Prior to LLETZ-conization informed consent no known hematologic disorder  significant language barrier a personal history of LLETZ-conization
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  LSIL, Low-Grade Squamous Intraepithelial Lesions Diagnosis of Low-Grade Squamous Intraepithelial Lesion by cervical cytology Positive Biopsy for Low-Grade Squamous Intraepithelial Lesion after colposcopy  Serological detection of human immunodeficiency virus (HIV)
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 25.0-999.0,  Uterine Cervical Dysplasia Papillomavirus Infections Sexually-active women Women with intact uterine cervix Voluntary written informed consent to participate in the study  Virgin women Pregnant or breast-feeding women, and women in the post-partum period Subject is already diagnosed with cervical cancer Medical history of any severe diseases like hepatitis, renal or liver dysfunction, cardiovascular, gastrointestinal, malignant tumor, or psychiatric disorders etc., which might influence the assessments or conduct of the trial by the discretion of the investigator Intake or application of antivirals or other prohibited concomitant medication within 30 days prior to application of AV2®, or patients who plan to take such drugs during the trial Known or suspected allergic or adverse response to the investigational product AV2 or its components (olive oil or d-limonene) Inability to follow the study protocol
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Intraepithelial Neoplasia Grade 2/3 High-risk HPV (Any Strain) ≥ 18 years Capable of informed consent HPV-positive by DNA test Histologically confirmed CIN 2, CIN 3, or CIN 2/3 Body weight ≥ 50 kg Immune competent  Pregnant and nursing women HIV seropositive Active autoimmune disease Taking immunosuppressive medication Evidence of concurrent adenocarcinoma in situ Concurrent malignancy except for nonmelanoma skin lesions
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 30.0-60.0,  CIN Married women attending the Preventive Oncology screening clinic women in age group 30 to 60 years  Unmarried women married women in the age group less than 30 years and above 60 years pregnant women women with history of total hysterectomy women with cervical cancer
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-50.0,  Cervical Intraepithelial Neoplasia • Clinical diagnosis of cervical pre-cancer  Pregnancy Feeding mother Bad nutritional state Infection Treatment for hypertension Diabetes for many years or complications Cardiovascular disease Serious anemia Cardial arrythmia Serious liver-disease
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Cervical Cancer Intraepithelial Neoplasia Women of all ages are eligible to the study if they have been referred to the participating colposcopy clinic because of an abnormal Pap test at the level of an atypical squamous cells of undetermined significance or worse squamous or glandular abnormality (i.e., ASCUS+) or an abnormal co-test (ASCUS+ and HPV-positive) result  none
Patient description: A Pap smear in a 54-year-old woman revealed abnormal cervical squamous intraepithelial/glandular lesion. She tested positive for HPV 16. She is sexually active with her husband and has 4 children. She is menopausal and uses no contraception. She smokes and drinks alcohol frequently. She is otherwise healthy. She was offered conization.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer Cervical Intraepithelial Neoplasias Digital Colposcopy Precancerous Cervical Lesions Women who are at least 18 years old Women who are not pregnant as confirmed by a urine test Women who are not breastfeeding Women who understand the study procedures and can provide written informed consent  Women who do not meet the Women who have had a hysterectomy